Analyst Ratings for ResMed (RMD)
RMD Rating Summary
RMD Price Target Summary
- Highest: $345.00 (UBS)
- Lowest: $180.00 (Wolfe Research)
- Average: $264.82
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$264.82 (+40.4%)
* Over Last 12-Mos
Rating Score: 5.2 / 10
Percentile Rank: 56%
Avg. $ Target:
$264.82 (+40.4%)
* Over Last 12-Mos
Rating Score: 5.2 / 10
Percentile Rank: 56%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/17/2026 | Morgan Stanley | David Bailey | Downgrade | Equalweight (Overweight) |
230.00 (286.00) |
192.74 (188.63) |
-2.13% | Details |
| 4/15/2026 | JPMorgan | N/A | New Coverage | Overweight (N/A) |
N/A (N/A) |
230.69 (188.63) |
-18.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
